News
After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic versions of Novo Nordisk’s lucrative semaglutide drugs for diabetes and obesi | ...
A woman on Ozempic has revealed why she gave her 11 year old daughter weight loss jabs, a similar drug called Wegovy, on This ...
HIMS stock up 16% on Wednesday, continuing month-long gains. Novo Nordisk ends partnership, cites misleading marketing and ...
A young woman details her experience with the newly available weight loss medication.
The new novel, out July 29 from Flatiron Books, follows a group of mothers whose children are enrolled at the ...
Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...
1d
Money Talks News on MSNWegovy Fallout: How Novo’s Exit Hits Your Wallet and WaistlineNovo Nordisk announced it is cutting ties with telehealth giant Hims & Hers Health, pulling its blockbuster drug Wegovy from ...
1d
Money Talks News on MSNYour Wegovy Access Just Changed: What Patients Need to Know NowNovo Nordisk just pulled Wegovy from a major telehealth platform over safety concerns about knockoff versions. Here's what ...
7h
Verywell Health on MSNWhat Happens to Your Body When You Stop Taking OzempicMany people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to know before stopping.
On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...
There are several strategies to help you control your portion sizes and avoid mindless snacking. We’ve all been there. You ...
A MOTHER who put her daughter on weight loss jabs at the age of 11 has opened up on her family’s experience with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results